Literature DB >> 19825322

Prevalence of fatal adverse drug reactions in hospitalized patients.

A J Pardo Cabello1, L G González Contreras, M V Manzano Gamero, F J Gómez Jiménez, E Puche Cañas.   

Abstract

OBJECTIVE: The aims of the present study were to assess the prevalence of fatal adverse drug reactions (FADRs) in a hospitalized population, identify the drugs involved and investigate reported risk factors for these events.
METHODS: The study population of this retrospective, single-centre case study comprised 289 patients dying between 1 January 2004 and 31 December 2004 and registered in the Cause of Death Register of a teaching hospital. All compiled data were recorded by two observers especially trained to identify and report adverse drug reactions (ADRs). The degree of probability that the ADR led directly to death was determined by using WHO criteria and an adapted version of Naranjo's score.
RESULTS: Among 289 deceased study subjects, 17 (5.9%) were suspected to have died from an ADR. The most common suspected FADRs were gastrointestinal hemorrhages (52.9%), central nervous system hemorrhages (17.6%), cardiac disorders (17.6%), drug-induced myelosuppression (6%) and antimicrobial-related enterocolitis (6%). The drugs most frequently implicated in a FADR were antithrombotic drugs (65%), nonsteroidal anti-inflammatory drugs (NSAIDs) (47%) and corticosteroids (29%). The only risk factors associated with FADRs in this population were multiple-drug therapy and the presence of platelet antiaggregants and NSAIDs, alone or associated.
CONCLUSIONS: FADRs are an important cause of death in hospitalized patients. Hemorrhages were seen in a majority of the fatal reactions, and antithrombotic agents or NSAIDs were implicated in most of these events.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19825322     DOI: 10.5414/cpp47596

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther        ISSN: 0946-1965            Impact factor:   1.366


  8 in total

Review 1.  Hospitalizations due to preventable adverse reactions-a systematic review.

Authors:  Nidhi S Patel; Tejas K Patel; Parvati B Patel; Viren N Naik; C B Tripathi
Journal:  Eur J Clin Pharmacol       Date:  2016-12-02       Impact factor: 2.953

2.  Drug-related deaths in hospital inpatients: A retrospective cohort study.

Authors:  Eva Montané; Ana Lucía Arellano; Yolanda Sanz; Josep Roca; Magí Farré
Journal:  Br J Clin Pharmacol       Date:  2018-01-11       Impact factor: 4.335

3.  Drug-related mortality among inpatients: a retrospective observational study.

Authors:  Alfredo José Pardo Cabello; Esperanza Del Pozo Gavilán; Francisco Javier Gómez Jiménez; Carmen Mota Rodríguez; Juan de Dios Luna Del Castillo; Emilio Puche Cañas
Journal:  Eur J Clin Pharmacol       Date:  2016-02-20       Impact factor: 2.953

Review 4.  The prevalence of medication-related adverse events in inpatients-a systematic review and meta-analysis.

Authors:  Outi Laatikainen; J Miettunen; S Sneck; H Lehtiniemi; O Tenhunen; M Turpeinen
Journal:  Eur J Clin Pharmacol       Date:  2017-09-05       Impact factor: 2.953

Review 5.  Number of drugs most frequently found to be independent risk factors for serious adverse reactions: a systematic literature review.

Authors:  Eva A Saedder; Marianne Lisby; Lars Peter Nielsen; Dorthe K Bonnerup; Birgitte Brock
Journal:  Br J Clin Pharmacol       Date:  2015-05-19       Impact factor: 4.335

6.  Prediction of clinically relevant adverse drug events in surgical patients.

Authors:  Jacqueline M Bos; Gerard A Kalkman; Hans Groenewoud; Patricia M L A van den Bemt; Peter A G M De Smet; J Elsbeth Nagtegaal; Andre Wieringa; Gert Jan van der Wilt; Cornelis Kramers
Journal:  PLoS One       Date:  2018-08-23       Impact factor: 3.240

7.  Aspirin Desensitization: Implications for Acetylsalicylic Acid-Sensitive Pregnant Women.

Authors:  Filipe Benito-Garcia; Inês Pires; Jorge Lima
Journal:  Medicina (Kaunas)       Date:  2021-04-17       Impact factor: 2.430

8.  Fatal adverse drug reactions: Experience of adverse drug reactions in a tertiary care teaching hospital of North India - A case series.

Authors:  Vishal R Tandon; Vijay Khajuria; Annil Mahajan; Zahid Gillani; Vivek Mahajan; Vijant Chandail
Journal:  Indian J Crit Care Med       Date:  2014-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.